Red Silurian wrote: » Novavax - Started rolling review on 3rd of February Curevax - Started roling review on 12th of February Sputnik V - Started rolling review on 4th of March Assuming all the above are accepted by the EMA (no guarantee obviously) the EMA should have them approved between 52 and 122 days from Rolling Review start meaning - Novavax - 8th April - 17th June Curevax - 17th April - 26th June Sputnik V - 25th April - July 4th
Red Silurian wrote: » I had a look this lunch time at the EMA's rolling review process and how long it took from the beginning of rolling review to approval Biontech - 72 days (1st October to 12th December) Moderna - 52 days (16th November to 6th January) Oxford/AZ - 122 days (30th September to 29th of January) Jansen (J&J) - 100 days (1st of December to 11th of March) There are obviously factors to consider but Under rolling review at the moment are Novavax - Started rolling review on 3rd of February Curevax - Started roling review on 12th of February Sputnik V - Started rolling review on 4th of March Assuming all the above are accepted by the EMA (no guarantee obviously) the EMA should have them approved between 52 and 122 days from Rolling Review start meaning - Novavax - 8th April - 17th June Curevax - 17th April - 26th June Sputnik V - 25th April - July 4th
Melanchthon wrote: » Said it before, will say it again, there's no evidence of any agreement with Novavax having been concluded with the EU despite it being really really promising. Somebody needs to ask Maread McGuiness or Micheal Martin to enquire about it at this stage.
titan18 wrote: » Ya, haven't seen anything that we actually have stuff ordered there.
josip wrote: » But if Anagni has 16m doses already there destined for the EU, why break it into 2 tranches and delay 6m vaccines getting into arms? Something about that 6m in April seems fishy.
Deleted User wrote: » Novovax are likely to seek UK and US approval before any submission to the EMA, I would presume as well given the AZ debacle they'll be very careful on the terms of any contract with the EU.
Deleted User wrote: » Batch release takes time and done on a batch by batch basis, with testing to be completed to ensure it meets predefined criteria. They dont just stick it in a vial and ship. The qualified person is an individual within a pharma plant who is responsible with ensuring all batches released meet the requirements fully. There are criminal consequences to that individual with not fulfilling those requirements
josip wrote: » How many doses in a typical batch? 1m, 10m, more?
RavenBea17b wrote: » Didn't they say that two or three months now in a row. I wonder what the sticking points are ? ?? Perhaps delivery schedule amongst others.
is_that_so wrote: » About a month ago it was "very close" to agreement. The EU have a provisional deal anyway. Has the AZ situation prompted a review/pause I wonder?
The envisaged contract with Novavax would provide for the possibility for all EU Member States to purchase 100 million doses, and they could further purchase up to 100 million more doses
Melanchthon wrote: » What does a provisional deal mean though. As I understand they have an agreement to reach an agreementhttps://ec.europa.eu/commission/presscorner/detail/en/ip_20_2305 That's the last official thing I can find, the stuff from the start of February was all "sources". I don't know anything really about contract law though but has there been any indication of if money has been handed over in terms of preliminary funding, as in say look at the UK and Astra Zeneca there was all that funding and agreements but not a final contract early. What's interesting is searched again there too see if anymore news and saw this.https://mobile.reuters.com/article/idUSKBN2AV19O "It has also secured eight million doses of Novavax's vaccine as part of EU joint purchases. " But that's weird, Reuters is normally good but isn't that for the exploration talks? Also it's strange to see figures for the Polish government giving money to build up production but no mention online of EU funds to Novavax unless I am missing it somewhere?
is_that_so wrote: » Novavax is under rolling review with the EMA, like CureVac and Sputnik V.
Apogee wrote: » https://twitter.com/lidl_ireland/status/1374381763066089487
is_that_so wrote: » I last saw it in about mid-February and it was "imminent". I believe they are stockpiling it anyway and Poland have done a deal with them.
embraer170 wrote: » I am getting very confused by the whole vaccine roll out. My father 86 got his first dose on 18 February and his second dose on St Patrick’s Day. All good. My mom (same GP) who turned 75 in early March has no news at all. She has a wide range of underlying conditions including three strokes. She called the doctor yesterday to ask and was told her first dose would not be before mid/end-April (!!). Asking about left-over doses from cancellations (willing to go at very short notice, and I read that living with an 85+ year old puts you on a priority list for cancellations), she was brushed off saying they never have any cancellations (hmmmm). All a bit frustrating.
Bubbaclaus wrote: » I wonder will we start getting our first 20k+ days in the data this week. Any update on latest deliveries?
Str8outtaWuhan wrote: » time to find a new GP
[Deleted User] wrote: » Rolling review means feck all until the company actually make a formal submission, which Novavax haven't done yet.
Micky 32 wrote: » https://twitter.com/jamespurvis21/status/1374791499934797829?s=21 :pac::pac: